Lates News

AI Express News, Open Source Securities released a research report on April 30th, giving Buy rating to Baiyang Medicine (301015.SZ). The rating reasons mainly include: 1) Brand operation business sales are steady, wholesale distribution business continues to narrow; 2) Innovative transformation and forward-looking layout, empowering future development. (Daily Economic News)